Demand for pharmaceutical fix-a-form labels could be set to rise after Qatar was named as the latest country to see growth in its pharma industry.

According to Business Monitor International (BMI), this expansion is likely to continue over the next few years.

The organisation said this will be fuelled by the continuing reliance on imports from overseas, as well as regulatory changes that should stimulate free market competition.

BMI stated that officials hope this will increase the availability of various pharmaceutical products and help to drive down prices.

Estimates from the organisation suggest that drug expenditure in Qatar will go up at a compound annual growth rate of 12.6 per cent during the next five years.

This means that the pharmaceutical industry in Qatar will be worth approximately £440 million by this time.

The forecast comes shortly after Research and Markets reported that the pharma sector in India is experiencing rapid growth.

Denny Bros Ltd, 25 March 2011